These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7957622)

  • 1. Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice.
    Yokoyama H; Onodera K; Maeyama K; Sakurai E; Iinuma K; Leurs R; Timmerman H; Watanabe T
    Eur J Pharmacol; 1994 Jul; 260(1):23-8. PubMed ID: 7957622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of thioperamide, a histamine H3 receptor antagonist, on electrically induced convulsions in mice.
    Yokoyama H; Onodera K; Iinuma K; Watanabe T
    Eur J Pharmacol; 1993 Mar; 234(1):129-33. PubMed ID: 8386092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clobenpropit (VUF-9153), a histamine H3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice.
    Miyazaki S; Onodera K; Imaizumi M; Timmerman H
    Life Sci; 1997; 61(4):355-61. PubMed ID: 9244361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial interaction between clobenpropit and pyridoxine in prevention of electroshock-induced seizures in mice: lack of histaminergic mechanisms.
    Uma Devi P; Manocha A; Khanam R; Vohora D
    Hum Exp Toxicol; 2011 Jan; 30(1):84-8. PubMed ID: 20511290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of clobenpropit, a centrally acting histamine H3-receptor antagonist, on electroshock- and pentylenetetrazol-induced seizures in mice.
    Fischer W; van der Goot H
    J Neural Transm (Vienna); 1998; 105(6-7):587-99. PubMed ID: 9826104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
    Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
    Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Thiazolylethylamine, a selective histamine H1 agonist, decreases seizure susceptibility in mice.
    Yokoyama H; Onodera K; Iinuma K; Watanabe T
    Pharmacol Biochem Behav; 1994 Mar; 47(3):503-7. PubMed ID: 7911577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AQ-0145, a newly developed histamine H3 antagonist, decreased seizure susceptibility of electrically induced convulsions in mice.
    Murakami K; Yokoyama H; Onodera K; Iinuma K; Watanabe T
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():70-3. PubMed ID: 8750799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clobenpropit on regional cerebral blood flow in rat hippocampus.
    Chen Z
    Acta Pharmacol Sin; 2001 Apr; 22(4):355-60. PubMed ID: 11742589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory H3 receptors on sympathetic nerves of the pithed rat: activation by endogenous histamine and operation in spontaneously hypertensive rats.
    Godlewski G; Malinowska B; Buczko W; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):261-6. PubMed ID: 9050021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonist.
    Barnes JC; Brown JD; Clarke NP; Clapham J; Evans DJ; O'Shaughnessy CT
    Eur J Pharmacol; 1993 Nov; 250(1):147-52. PubMed ID: 8119312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of alpha-fluoromethylhistidine and metoprine.
    Yokoyama H; Onodera K; Maeyama K; Yanai K; Iinuma K; Tuomisto L; Watanabe T
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):40-5. PubMed ID: 1407004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H3 receptor-mediated inhibition of sympathetically evoked mydriasis in rats.
    Yu Y; Kawarai M; Koss MC
    Eur J Pharmacol; 2001 May; 419(1):55-9. PubMed ID: 11348630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo modulation of rat hypothalamic histamine release by the histamine H3 receptor ligands, immepip and clobenpropit. Effects of intrahypothalamic and peripheral application.
    Jansen FP; Mochizuki T; Yamamoto Y; Timmerman H; Yamatodani A
    Eur J Pharmacol; 1998 Dec; 362(2-3):149-55. PubMed ID: 9874165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
    Cardell LO; Edvinsson L
    Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of histamine H3-receptor antagonist clobenpropit on spatial memory of radial maze performance in rats.
    Chen Z
    Acta Pharmacol Sin; 2000 Oct; 21(10):905-10. PubMed ID: 11501041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of histamine H3-receptor antagonists on amygdaloid kindled seizures in rats.
    Kakinoki H; Ishizawa K; Fukunaga M; Fujii Y; Kamei C
    Brain Res Bull; 1998 Jul; 46(5):461-5. PubMed ID: 9739010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioperamide, a histamine H3 receptor antagonist, increases GABA release from the rat hypothalamus.
    Yamamoto Y; Mochizuki T; Okakura-Mochizuki K; Uno A; Yamatodani A
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):289-98. PubMed ID: 9379777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist.
    Liu CQ; Hu DN; Liu FX; Chen Z; Luo JH
    Pharmacol Biochem Behav; 2008 Sep; 90(3):325-30. PubMed ID: 18452981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of histamine H3 receptor ligands in experimental models of anxiety and depression.
    Pérez-García C; Morales L; Cano MV; Sancho I; Alguacil LF
    Psychopharmacology (Berl); 1999 Feb; 142(2):215-20. PubMed ID: 10102775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.